FitLife Brands (FTLF) Competitors $13.64 -0.82 (-5.67%) Closing price 04:00 PM EasternExtended Trading$13.72 +0.07 (+0.55%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. VECT, SION, KROS, IMTX, COGT, TYRA, VALN, MRVI, RLAY, and GHRSShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Cogent Biosciences (COGT), Tyra Biosciences (TYRA), Valneva (VALN), Maravai LifeSciences (MRVI), Relay Therapeutics (RLAY), and GH Research (GHRS). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. VectivBio Sionna Therapeutics Keros Therapeutics Immatics Cogent Biosciences Tyra Biosciences Valneva Maravai LifeSciences Relay Therapeutics GH Research VectivBio (NASDAQ:VECT) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings. Does the media favor VECT or FTLF? In the previous week, FitLife Brands had 8 more articles in the media than VectivBio. MarketBeat recorded 8 mentions for FitLife Brands and 0 mentions for VectivBio. FitLife Brands' average media sentiment score of 0.36 beat VectivBio's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral FitLife Brands Neutral Which has stronger earnings & valuation, VECT or FTLF? FitLife Brands has higher revenue and earnings than VectivBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/AFitLife Brands$64.47M1.99$5.30M$0.8416.24 Do analysts recommend VECT or FTLF? FitLife Brands has a consensus target price of $20.50, indicating a potential upside of 50.29%. Given FitLife Brands' stronger consensus rating and higher probable upside, analysts clearly believe FitLife Brands is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more volatility & risk, VECT or FTLF? VectivBio has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Does the MarketBeat Community believe in VECT or FTLF? VectivBio received 7 more outperform votes than FitLife Brands when rated by MarketBeat users. However, 60.00% of users gave FitLife Brands an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% FitLife BrandsOutperform Votes360.00% Underperform Votes240.00% Do institutionals and insiders believe in VECT or FTLF? 2.3% of FitLife Brands shares are owned by institutional investors. 9.7% of VectivBio shares are owned by insiders. Comparatively, 61.3% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is VECT or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to VectivBio's net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat VectivBio's return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A FitLife Brands 13.38%28.03%15.13% SummaryFitLife Brands beats VectivBio on 15 of the 17 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$128.00M$1.22B$5.37B$8.51BDividend YieldN/AN/A4.95%4.14%P/E Ratio16.1411.4126.8319.76Price / Sales1.998.63396.51122.12Price / Cash19.0510.4038.2534.62Price / Book4.491.446.754.59Net Income$5.30M-$56.07M$3.23B$248.34M7 Day Performance-12.51%3.70%4.35%5.01%1 Month Performance15.59%25.86%11.03%14.61%1 Year Performance-3.30%-37.55%14.52%6.88% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.5394 of 5 stars$13.64-5.7%$20.50+50.3%-2.4%$128.00M$64.47M16.1420News CoverageEarnings ReportVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeSIONSionna TherapeuticsN/A$12.90+4.7%$38.50+198.4%N/A$569.20MN/A0.0035News CoverageEarnings ReportKROSKeros Therapeutics3.2001 of 5 stars$13.74+0.7%$37.00+169.3%-74.2%$558.05M$214.71M-2.64100IMTXImmatics2.8761 of 5 stars$4.56+7.5%$16.67+265.5%-57.7%$554.27M$155.84M-6.91260News CoveragePositive NewsEarnings ReportAnalyst RevisionCOGTCogent Biosciences2.4287 of 5 stars$5.13+6.7%$14.29+178.5%-38.2%$547.65MN/A-2.0780Positive NewsTYRATyra Biosciences1.715 of 5 stars$10.26+1.7%$30.83+200.5%-46.5%$544.70MN/A-6.3720News CoveragePositive NewsVALNValneva2.3656 of 5 stars$6.45-0.3%$15.50+140.3%-30.7%$539.45M$169.58M-49.62700MRVIMaravai LifeSciences4.1372 of 5 stars$2.12+7.1%$6.34+199.2%-82.5%$539.19M$259.19M-1.29610Earnings ReportAnalyst ForecastOptions VolumeRLAYRelay Therapeutics3.3612 of 5 stars$3.11+3.7%$17.67+468.1%-58.9%$533.19M$7.68M-1.19330GHRSGH Research2.5811 of 5 stars$10.16-2.1%$30.43+199.5%-16.0%$528.60MN/A-12.8610News CoverageAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies VectivBio Competitors Sionna Therapeutics Competitors Keros Therapeutics Competitors Immatics Competitors Cogent Biosciences Competitors Tyra Biosciences Competitors Valneva Competitors Maravai LifeSciences Competitors Relay Therapeutics Competitors GH Research Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FTLF Stock Free FTLF Stock Alerts